Table 2.
Time | Control group | Model group | Rosiglitazone-treatedgroup | |||
---|---|---|---|---|---|---|
DAI | CMDI | DAI | CMDI | DAI | CMDI | |
7th day | 0.06 ± 0.14 | 0.00 ± 0.00 | 2.89 ± 0.00* | 4.83 ± 0.55* | 2.69 ± 0.25 | 4.51 ± 0.41 |
14th day | 0.08 ± 0.14 | 0.00 ± 0.00 | 2.41 ± 0.25* | 4.07 ± 0.75* | 1.89 ± 0.35Δ | 3.42 ± 0.52Δ |
21st day | 0.00 ± 0.00 | 0.00 ± 0.00 | 2.09 ± 0.25* | 3.03 ± 0.52* | 1.53 ± 0.25Δ | 2.00 ± 0.55Δ |
35th day | 0.00 ± 0.00 | 0.00 ± 0.00 | 1.63 ± 0.46* | 2.33 ± 0.52* | 0.72 ± 0.28Δ | 1.50 ± 0.55Δ |
Note: *P < 0.05 versus control group, Δ P < 0.05 versus model group.